跳至主要内容
临床试验/NCT03690895
NCT03690895已完成不适用

Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy

Fondation Ophtalmologique Adolphe de Rothschild1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2015年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
51
试验地点
1
主要终点
Median duration of survival after diagnosis of lymphoma (years)

研究概览

简要总结

This study aims at describing survival rates over time (Kaplan-Meier estimator) in patients suffering from AIDS-related primary central nervous system lymphoma who were diagnosed from 1996 to 2014 and treated with infusions of high-dose methotrexate and combined antiretroviral therapy.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV infection
  • AIDS-related primary central nervous system lymphoma
  • treated with at least one infusion of methotrexate and combine antiretroviral therapy

排除标准

  • prior non-Hodgkin lymphoma

结局指标

主要结局

Median duration of survival after diagnosis of lymphoma (years)

时间窗: At the time of systematic files review (jan 2014) - average follow-up 7 years

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验